semaglutide compounding news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounding pharmacies to halt semaglutide

How much does it cost at Moonshot

Notably, while AP/NTS neurons express GLP-1Rs [3, 47], inhibiting GLP-1R-expressing AP neurons does not prevent the appetite-suppressing effects of endogenously released GLP-1 [39], likely because of low amounts of GLP-1 reaching these neurons due to rapid GLP-1 degradation by the enzyme dipeptidylpeptidase IV (DPPIV) [48]

Patel explains how oxidative stress affects the brain first, why inflammation is rising globally, and how restoring glutathione may help support clarity, recovery, and long-term cognitive performance

Tranexamic acid (topical): Investigated in clinical trials for melasma with more robust evidence than IV glutathione